mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
5e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
9e-05 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |